➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
McKinsey
Colorcon
Dow

Last Updated: December 4, 2020

DrugPatentWatch Database Preview

Claims for Patent: 10,022,510

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,022,510
Title:Dose counters for inhalers, inhalers and methods of assembly thereof
Abstract: A tape system for a dose counter for an inhaler, the tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the tape, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and one end of the tape.
Inventor(s): Walsh; Declan (County Kilkenny, IE), Fenlon; Derek (County Wexford, IE), Kaar; Simon (County Cork, IE), Hazenberg; Jan Geert (County Kilkenny, IE), Buck; Daniel (County Waterford, IE), Clancy; Paul (Waterford, IE), Uschold; Robert Charles (Leominster, MA), Karg; Jeffrey A. (Hopkinton, MA)
Assignee: Ivax Pharmaeuticals Ireland (Waterford, IE) Norton (Waterford) Limited (Waterford, IE) Teva Pharmaceuticals Ireland (Waterford, IE)
Application Number:15/271,738
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,022,510
Patent Claims: 1. An inhaler comprising a dose counter and dose counter viewing window, the inhaler being configured to be readied by priming before first use and the dose counter comprising: a tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the main elongate tape structure, and priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and a first end of the main elongate tape structure and visible in the dose counter viewing window before priming before first use, and wherein the first end of the main elongate tape structure is fixed to a tape reel shaft and a second end of the main elongate tape structure is attached to a stock bobbin, and wherein the main elongate tape structure is around both the stock bobbin and tape reel shaft when the priming indicia is visible in the dose counter viewing window before priming before first use.

2. The inhaler of claim 1, wherein the dosing indicia comprise numbers printed on the main elongate tape structure.

3. The inhaler of claim 1, wherein the priming indicia is a priming dot located on the main elongate tape structure that is to be aligned with the viewing window on the inhaler that is visible to a user of the inhaler.

4. The inhaler of claim 1, wherein the tape positioning indicia comprise a series of lines that are each formed across the main elongate tape structure.

5. The inhaler of claim 1, wherein the tape size marker is positioned between said one the first end of the main elongate tape structure and the tape positioning indicia.

6. The inhaler of claim 1, wherein the tape positioning indicia are positioned between the first end of the main elongate tape structure and the dosing indicia.

7. The inhaler of claim 1, wherein the first end of the main elongate tape structure is fixed to the tape reel shaft.

8. The inhaler of claim 1, wherein the priming indicia is positioned between the dosing indicia and the tape positioning indicia.

9. The inhaler of claim 1, wherein the tape size marker is a pixelated bar code.

10. An inhaler comprising a dose counter and dose counter viewing window, the inhaler being configured to be readied by priming before first use and the dose counter comprising: a tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure, and a tape size marker located on the main elongate tape structure indicating a number of dosing indicia on the main elongate tape structure, wherein the tape size marker is positioned between a first end of the main elongate tape structure and the tape positioning indicia, wherein the first end of the main elongate tape structure is fixed to a tape reel shaft and a second end of the main elongate tape structure is attached to a stock bobbin, and wherein the tape is around both the stock bobbin and tape reel shaft and a portion of the main elongate tape structure between the tape positioning indicia and the dosing indicia is visible in the dose counter viewing window before priming before first use.

11. The inhaler of claim 10, wherein the dosing indicia comprise numbers printed on the main elongate tape structure.

12. The inhaler of claim 10, wherein the tape positioning indicia comprise a series of lines that are each formed across the main elongate tape structure.

13. The inhaler of claim 10, wherein the tape size marker is positioned between the first end of the main elongate tape structure and the dosing indicia.

14. The inhaler of claim 10, wherein the tape size marker is a pixelated bar code.

15. The inhaler of claim 10, wherein said the first of the main elongate tape structure is fixed to the tape reel shaft.

16. The inhaler of claim 10 further comprising priming indicia located on the main elongate tape structure, the priming indicia being located between the dosing indicia and the first end of the main elongate tape structure.

17. The inhaler of claim 16, wherein the tape positioning indicia are positioned between the first end of the tape and the dosing indicia.

18. The inhaler of claim 16, wherein the priming indicia are positioned between the dosing indicia and the tape positioning indicia.

19. The inhaler of claim 16, wherein the priming indicia is a priming dot located on the main elongate tape structure that is to be aligned with the viewing window.

20. An inhaler comprising a dose counter and dose counter viewing window, the inhaler being configured to be readied by priming before first use and the dose counter comprising: a tape system having a main elongate tape structure, dosing indicia located on the main elongate tape structure, tape positioning indicia located on the main elongate tape structure so as to be visible in the dose counter viewing window before priming before first use, and priming indicia located on the main elongate tape structure, the priming indicia being located between the tape positioning indicia and the dosing indicia, wherein a first end of the main elongate tape structure is attached to a stock bobbin and a second end of the main elongate tape structure is fixed to a tape reel shaft, and wherein the main elongate tape structure is around both the stock bobbin and tape reel shaft when the priming indicia is visible in the dose counter viewing window before priming before first use.

21. The inhaler of claim 20, wherein the dosing indicia comprise numbers printed on the main elongate tape structure.

22. The inhaler of claim 20, wherein the priming indicia is a priming dot located on the main elongate tape structure that is to be aligned with the viewing window on the inhaler that is visible to a user of the inhaler.

23. The inhaler of claim 20, wherein the tape positioning indicia comprise a series of lines that are each formed across the main elongate tape structure.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Colorcon
Medtronic
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.